Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216483.RA2Nf_6CejWP5e2ei_ui0DfrabQ0JbtTGEOUgv3-LhrXI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216483.RA2Nf_6CejWP5e2ei_ui0DfrabQ0JbtTGEOUgv3-LhrXI130_assertion type Assertion NP1216483.RA2Nf_6CejWP5e2ei_ui0DfrabQ0JbtTGEOUgv3-LhrXI130_head.
- NP1216483.RA2Nf_6CejWP5e2ei_ui0DfrabQ0JbtTGEOUgv3-LhrXI130_assertion description "[Although triethylenemelamine is no longer prescribed, our findings warrant further follow-up to investigate potential SMN risks associated with current chemotherapies used for Rb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216483.RA2Nf_6CejWP5e2ei_ui0DfrabQ0JbtTGEOUgv3-LhrXI130_provenance.
- NP1216483.RA2Nf_6CejWP5e2ei_ui0DfrabQ0JbtTGEOUgv3-LhrXI130_assertion evidence source_evidence_literature NP1216483.RA2Nf_6CejWP5e2ei_ui0DfrabQ0JbtTGEOUgv3-LhrXI130_provenance.
- NP1216483.RA2Nf_6CejWP5e2ei_ui0DfrabQ0JbtTGEOUgv3-LhrXI130_assertion SIO_000772 25185089 NP1216483.RA2Nf_6CejWP5e2ei_ui0DfrabQ0JbtTGEOUgv3-LhrXI130_provenance.
- NP1216483.RA2Nf_6CejWP5e2ei_ui0DfrabQ0JbtTGEOUgv3-LhrXI130_assertion wasDerivedFrom befree-2016 NP1216483.RA2Nf_6CejWP5e2ei_ui0DfrabQ0JbtTGEOUgv3-LhrXI130_provenance.
- NP1216483.RA2Nf_6CejWP5e2ei_ui0DfrabQ0JbtTGEOUgv3-LhrXI130_assertion wasGeneratedBy ECO_0000203 NP1216483.RA2Nf_6CejWP5e2ei_ui0DfrabQ0JbtTGEOUgv3-LhrXI130_provenance.